{"pageContent": "Background and purpose: To determine the kinetics of serum prostate-specific antigen (PSA) after radiation therapy of localized prostate cancer and to evaluate whether such kinetics provide prognostic information.", "metaData": {"source": "Tissue disposition of 5-o-carboranyluracil--a novel agent for the boron neutron capture therapy of prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/15043155/"}}